1. Sakalis VI, Karavitakis M, Bedretdinova D, Bach T, Bosch JLHR, Gacci M, et al. Medical treatment of nocturia in men with lower urinary tract symptoms: systematic review by the european association of urology guidelines panel for male lower urinary tract symptoms. Eur Urol. 2017 Nov;72(5):757–69.
2. Clemens JQ, Wiseman JB, Smith AR, Amundsen CL, Yang CC, Bradley MS, et al. Prevalence, subtypes, and correlates of nocturia in the symptoms of lower urinary tract dysfunction research network cohort. Neurourol Urodyn. 2020 Apr;39(4):1098–107.
3. Michel MC. Where will the next generation of medical treatments for overactive bladder syndrome come from? Int J Urol. 2020 Apr;27(4):289–94.
4. Camões J, Coelho A, Castro-Diaz D, Cruz F. Lower urinary tract symptoms and aging: the impact of chronic bladder ischemia on overactive bladder syndrome. Urol Int. 2015;95(4):373–9.
5. Foley S, Choudhury N, Huang M, Stari A, Nazir J, Freeman R. Quality of life in patients aged 65 years and older with overactive bladder treated with mirabegron across eight European countries: secondary analysis of BELIEVE. Int J Urol. 2019 Sep;26(9):890–6.